Aarti Pharmalabs Limited (NSE:AARTIPHARM)
India flag India · Delayed Price · Currency is INR
731.20
-1.45 (-0.20%)
Mar 12, 2025, 3:30 PM IST

Aarti Pharmalabs Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Market Capitalization
66,39739,41824,999---
Market Cap Growth
36.04%57.68%----
Enterprise Value
69,26740,89226,947---
Last Close Price
732.65432.77273.41---
PE Ratio
26.6418.1712.92---
PS Ratio
3.232.131.29---
PB Ratio
3.572.241.60---
P/TBV Ratio
3.522.351.65---
P/FCF Ratio
-64.8816.89---
P/OCF Ratio
-18.2210.00---
EV/Sales Ratio
3.372.211.39---
EV/EBITDA Ratio
15.9510.597.88---
EV/EBIT Ratio
19.6213.079.64---
EV/FCF Ratio
-67.3118.21---
Debt / Equity Ratio
0.210.160.140.250.080.08
Debt / EBITDA Ratio
0.890.740.631.65--
Debt / FCF Ratio
-4.701.45---
Asset Turnover
-0.770.911.18--
Inventory Turnover
-1.702.24---
Quick Ratio
-0.900.860.8011.42-
Current Ratio
-1.941.941.7711.42-
Return on Equity (ROE)
-13.08%13.14%17.63%-2.00%-
Return on Assets (ROA)
-8.10%8.16%10.10%-1.15%-
Return on Capital (ROIC)
10.72%10.25%9.98%11.92%-1.16%-
Return on Capital Employed (ROCE)
-16.57%17.01%11.30%--
Earnings Yield
3.75%5.50%7.74%---
FCF Yield
1.54%5.92%---
Dividend Yield
0.48%0.69%0.73%---
Payout Ratio
0.00%8.36%9.37%---
Buyback Yield / Dilution
-0.01%-0.01%--36150.40%--
Total Shareholder Return
0.46%0.68%0.73%-36150.40%--
Source: S&P Capital IQ. Standard template. Financial Sources.